Incident depression increases medical utilization in Medicaid patients with hypertension

References

• Blanchette CM, Simoni-Wastila L, Shaya FT, et al. Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiol Res Pract 2009;2009:194528
   PubMedGoogle Scholar
• Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008;300:2161-71
   PubMed Web of Science ®Google Scholar
• Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis 2013;55:511-23
   PubMed Web of Science ®Google Scholar
• Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA 2006;295:2874-81
   PubMed Web of Science ®Google Scholar
• Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003;54:248-61
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902
   PubMed Web of Science ®Google Scholar
• Huffman JC, Celano CM, Beach SR, et al. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013;2013:695925
   PubMedGoogle Scholar
• Rutledge T, Linke SE, Johnson BD, et al. Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women. J Womens Health 2011;21:133-9
   Web of Science ®Google Scholar
• Rodwin BA, Spruill TM, Ladapo JA. Economics of Psychosocial Factors in Patients with Cardiovascular Disease. Prog Cardiovasc Dis 2013;15:563-73
   Google Scholar
• Plante G. Depression and cardiovascular disease: a reciprocal relationship. Metabolism 2005;54:45-8
   PubMed Web of Science ®Google Scholar
• Scalco AZ, Scalco MZ, Azul JB, Lotufo Neto F. Hypertension and Depression. Clinics 2005;60:241-50
   PubMedGoogle Scholar
• Wells KB. The role of depression in hypertension-related mortality. Psychosom Med 1995;57:436-8
   PubMed Web of Science ®Google Scholar
• Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 2006;21:850-3
   PubMed Web of Science ®Google Scholar
• Bolu A, Erdem M, Balıkcı A, et al. The relationship between serum levels of haptoglobin and neopterin and the number of episodes in patients with major depression. Journal of Mood Disorders 2013;3:1-7
   Google Scholar
• Maes M, Leonard BE, Myint AM, et al. The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;5:702-21
   Google Scholar
• Maes M, Ringel K, Kubera M, et al. Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord 2012;136:386-92
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Internal Med 2000;160:2101-7
   PubMed Web of Science ®Google Scholar
• Grenard JL, Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Internal Med 2011;26:1175-82
   PubMed Web of Science ®Google Scholar
• Wing RR, Phelan S, Tate D. The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res 2002;53:877-81
   PubMed Web of Science ®Google Scholar
• Sjosten N, Nabi H, Westerlund H, et al. Effect of depression onset on adherence to medication among hypertensive patients: a longitudinal modeling study. J Hypertens 2013;31:1477-84
   PubMed Web of Science ®Google Scholar
• Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007;120:26-32
   PubMed Web of Science ®Google Scholar
• Wang PS, Bohn RL, Knight E. Noncompliance with antihypertensive medications. The impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002;17:504-11
   PubMed Web of Science ®Google Scholar
• Kim MT, Han HR, Hill MN, et al. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med 2003;26:24-31
   PubMed Web of Science ®Google Scholar
• Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav 2009;36:127-37
   PubMed Web of Science ®Google Scholar
• Maguire LK, Hughes CM, McElnay JC. Exporing the impact of depressive symptoms and medication beliefs on medication adherence in hypertension: a primary care study. Patient Educ Councel 2008;73:371-6
   PubMed Web of Science ®Google Scholar
• Hashmi SK, Afridi MB, Abbas K, et al. Factors associated with adherence to antihypertensive treatment in Pakistan. PLoS One 2007;2:e280
   Web of Science ®Google Scholar
• Kim EY, Han H-R, Jeong S, et al. Does knowledge matter? Intentional medication nonadherence among middle-aged Korean Americans with high-blood pressure. J Cardiovasc Nurs 2007;22:397-404
   PubMed Web of Science ®Google Scholar
• Licht C, de Geus EJC, Seldenrijk A, et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009;53:631-8
   PubMed Web of Science ®Google Scholar
• Dawood T, Lamber EA, Barton DA, et al. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007;30:285-93
   PubMed Web of Science ®Google Scholar
• Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61
   PubMed Web of Science ®Google Scholar
• Krousel-Wood MA, Frohlich ED. Hypertension and depression: coexisting barriers to medication adherence. J Clin Hypertens 2010;12:481-6
   Web of Science ®Google Scholar
• Bivanco-Lima D, de Souza Santos I, Vannucchi AM, de Almeida Ribeiro MC. Cardiovascular risk in individuals with depression. Rev Assoc Med Bras 2013;59:298-304
   PubMed Web of Science ®Google Scholar
• Druss BG, Bradford D, Rosenheck RA, et al. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 2001;58:565-72
   PubMed Web of Science ®Google Scholar
• Kisely S, Smith M, Lawrence D, et al. Intequitable access for mentally ill patients to some medically necessary procedures. CMAJ 2007;176:779-84
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Agerbo E, et al. Somatic hospital contacts, invasive cardiac procedures and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 2009;66:713-20
   PubMed Web of Science ®Google Scholar
• Funk M, Drew N, Freeman M, Faydi E. World Health Organization. Mental health and development: targeting people with mental health conditions as a vulnerable group. World Health Organization; Geneve: 2010
   Google Scholar
• Onukwugha EO, Mullins CD, Weir MR, et al. Readmissions after Unauthorized Discharges in the Cardiovascular Setting. Med Care 2011;49:215-24
   PubMed Web of Science ®Google Scholar
• Himelhoch S, Weller WE, Wu AW, et al. Chronic medical illness, depression, and use of acute medical services among medicare beneficiaries. Med Care 2004;42:512-21
   PubMed Web of Science ®Google Scholar
• Wooldridge JM. Econometric analysis of cross section and panel data. MIT Press; Cambridge, MA: 2002
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
   PubMedGoogle Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
   PubMed Web of Science ®Google Scholar
• White WB, Moon T. Treatment of benign prostatic hyperplasia in hypertensive men. J Clin Hypertens (Greenwhich) 2005;7:212-17
   PubMedGoogle Scholar
• Johnson W, Shaya FT, Khanna N, et al. The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a Randomized Trial of the Effect of Education on Improving Blood Pressure Control in a Largely African American Population. J Clin Hypertens 2011;13:563-70
   PubMed Web of Science ®Google Scholar
• Shaya FT, Chirikov VV, Mullins CD, et al. Social Networks Help Control Hypertension. J Clin Hypertens 2013;15:34-40
   Web of Science ®Google Scholar
• Shaya FT, Yan X, Lin P, et al. U.S. Trends in Glycemic Control, Treatment and Comorbidity Burden in Patients with Diabetes. J Clin Hypertens 2010;12:826-32
   Web of Science ®Google Scholar
• Shaya FT, Du D, Akazawa M, et al. Burden of concomitant asthma and copd in a medicaid population. Chest 2008;134:14-19
   PubMed Web of Science ®Google Scholar
• Wang J, Mullins CD, Mamdani M, et al. New Diagnosis of Hypertension among Celecoxib and Non-Selective NSAID Users: a Population-Based Cohort Study. Ann of Pharmacother 2007;41:937-43
   PubMed Web of Science ®Google Scholar
• Li C, Ford ES, Zhao G, et al. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the behavioral risk factor surveillance system, 2006. Diabetes Res Clin Pract 2009;83:268-79
   PubMed Web of Science ®Google Scholar
• Das AK, Olfson M, McCurtis HL, Weissman MM. Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract 2006;55:30-9
   PubMed Web of Science ®Google Scholar
• Breunig IM, Shaya FT, Scharf SM. Delivering Cost-Effective Care for COPD in the United States: recent Progress and Current Challenges. Expert Rev Pharmacoecon Outcomes Res 2012;12:725-35
   PubMed Web of Science ®Google Scholar